Terms & Properties |
Preferred Name: Talazoparib
Definition: An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Talazoparib selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks.
Display Name: Talazoparib
Label: Talazoparib
NCI Thesaurus Code: C95733 (Search for linked caDSR metadata) (search value sets)
NCI Metathesaurus Link: C2987384 (see NCI Metathesaurus info)
Synonyms & Abbreviations: (see Synonym Details)
BMN-673 |
BMN 673 |
Talazoparib |
External Source Codes:
PDQ Closed Trial Search ID | 694964 |
PDQ Open Trial Search ID | 694964 (check for NCI PDQ open clinical trial info) |
UMLS CUI | C2987384 |
Other Properties:
Name | Value (qualifiers indented underneath) |
---|---|
code | C95733 |
Contributing_Source | CTRP |
Semantic_Type | Pharmacologic Substance |
Additional Concept Data:
Defined Fully by Roles: No |
URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95733 |
No hay comentarios:
Publicar un comentario